Short Communication:Preclinical Evaluation of Candidate HIV Type 1 Vaccines in Inbred Strains and an Outbred Stock of Mice
- 1 July 2007
- journal article
- research article
- Published by Mary Ann Liebert Inc in AIDS Research and Human Retroviruses
- Vol. 23 (7) , 857-862
- https://doi.org/10.1089/aid.2007.0009
Abstract
Outstanding animal immunogenicity is a prerequisite for progression of novel vaccines to clinical trials. The measurement of vaccine immunogenicity is critically dependent on the specificity, accuracy, sensitivity, and precision of the employed assays. This has been greatly aided by the generation of isogenic mouse strains. Here, we identified three novel H-2d -restricted CD8+ T cell epitopes derived from the human immunodeficiency virus type 1 and demonstrated a fine evaluation of the vaccine-elicited T cell responses in an inbred mouse strain. However, unlike inbred mice, outbred mouse stock indicated preferential induction of CD4+ T cell responses by a heterologous DNA-prime-recombinant modified vaccinia virus Ankara boost regimen and induction of dominant responses to the env-derived vaccine component, i.e., observations reminiscent of human data. Thus, an outbred mouse stock may provide more rigorous and realistic tests for candidate vaccine evaluation in addition to sensitive assays in a selected, well-responding inbred strain.Keywords
This publication has 27 references indexed in Scilit:
- Combined single‐clade candidate HIV‐1 vaccines induce T cell responses limited by multiple forms of in vivo immune interferenceEuropean Journal of Immunology, 2007
- Clinical experience with plasmid DNA- and modified vaccinia virus Ankara-vectored human immunodeficiency virus type 1 clade A vaccine focusing on T-cell inductionJournal of General Virology, 2007
- Induction of long‐lasting multi‐specific CD8+ T cells by a four‐component DNA‐MVA/HIVA‐RENTA candidate HIV‐1 vaccine in rhesus macaquesEuropean Journal of Immunology, 2006
- Induction of Multifunctional Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T Cells Capable of Proliferation in Healthy Subjects by Using a Prime-Boost Regimen of DNA- and Modified Vaccinia Virus Ankara-Vectored Vaccines Expressing HIV-1 Gag Coupled to CD8+T-Cell EpitopesJournal of Virology, 2006
- Induction of Human Immunodeficiency Virus Type 1-Specific T Cells by a Bluetongue Virus Tubule-Vectored Vaccine Prime-Recombinant Modified Virus Ankara Boost RegimenJournal of Virology, 2005
- Short‐ and Long‐Term Immune Responses of CD‐1 Outbred Mice to the Scrub Typhus DNA Vaccine Candidate: p47KpAnnals of the New York Academy of Sciences, 2005
- Vaccine route, dose and type of delivery vector determine patterns of primary CD8+ T cell responsesEuropean Journal of Immunology, 2005
- Engineering RENTA, a DNA prime-MVA boost HIV vaccine tailored for Eastern and Central AfricaGene Therapy, 2004
- DiscussionNeurobiology of Aging, 1999
- Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malariaNature, 1989